Form Health Selected for Novo Nordisk’s NovoCare® Platform to Expand Access to Science-Based Obesity Care Across the United States

Telehealth Provider Selected for Its Commitment to Clinical Best Practices and Comprehensive Obesity Care
Business Wire
/
August 27, 2025

Boston, MA, August 27, 2025 - Today, Form Health, the leading provider of science-based obesity and cardiometabolic care in the United States, announced its selection as a healthcare provider option on Novo Nordisk’s NovoCare® platform. NovoCare® connects patients seeking treatment for chronic care with trusted healthcare providers, and Form Health’s inclusion will expand access to high-quality, evidence-based care delivered by trained Obesity Medicine Clinicians and Registered Dietitians. The relationship underscores Form Health’s commitment to clinical best practices; comprehensive, personalized treatment plans; and the avoidance of non-FDA approved compounded products that may expose patients to safety risks.

"Form’s mission has always been to make high-quality, science-based care accessible to everyone who needs it," said Evan Richardson, Founder and CEO of Form Health. "Being selected for the NovoCare® platform allows us to reach more patients living with obesity across the United States with evidence-based treatment, delivered by board-certified clinicians, and free from the shortcuts and unsafe practices that undermine patient safety. We’re proud to collaborate with Novo Nordisk in helping more people receive the care they deserve."

"At Novo Nordisk, we’re committed to helping people living with obesity and cardiometabolic conditions access safe, effective, and reliable care," said Dave Moore, Executive Vice President of US Operations at Novo Nordisk. "Form Health’s independent, clinician-led approach and dedication to high clinical standards align with our mission, and we look forward to connecting more patients with expert care teams through NovoCare®."

Form Health is one of a select group of telehealth providers available through the NovoCare® platform. Novo Nordisk selected telehealth organizations who align closely with its mission to expand access to reliable, high-quality care for people living with obesity. Providers are chosen for their commitment to following clinical guidelines and delivering dedicated, evidence-based support to every patient.

Florencia Halperin, MD, MMSc, Chief Medical Officer of Form Health, added, "Obesity and related cardiometabolic conditions require more than a prescription; they demand comprehensive, reliable care. Through Form Health, patients will have access to dedicated clinical teams, who combine the latest scientific evidence with nutrition, physical activity, and behavioral support to deliver sustainable, long-term health improvements."

 

About Form Health

Form Health is the national leader in science-based obesity care. Our clinical care model consists of one-on-one, personalized care delivered by a care team, led by an ABOM-certified physician. Our care teams also include Advanced Practice Providers and Registered Dietitians with specialized training in obesity treatment who develop individualized treatment plans that address behavioral health, nutrition, and physical activity, and include a prescription for FDA-approved medication, if appropriate. Form Health keeps safety, efficacy, and outcomes at the forefront as we incorporate the latest research and science into our approach. This means we’re always innovating, constantly getting smarter about the science of obesity care, relentlessly focusing on exceptional results, and calling out harmful practices that hold back progress. The result is life-changing outcomes for our patients and meaningful ROI for our enterprise partners. Form Health is in-network with national health plans. Learn more at formhealth.co